Navigation Links
Greater Baltimore Committee to Announce Winners of Third Baltimore Region Bioscience Awards at Ceremonies on March 18
Date:3/17/2008

BALTIMORE, March 17 /PRNewswire-USNewswire/ -- The following was issued today by the Greater Baltimore Committee:

WHO:

Donald C. Fry, president & CEO, Greater Baltimore Committee

140 company owners, executives and researchers from the Baltimore-area bioscience community

WHAT:

The third annual Greater Baltimore Region Bioscience Awards

WHEN:

Tuesday, March 18, 2008

8:00 a.m. / Breakfast & Registration

8:45 - 9:30 a.m. / Awards Program

WHERE:

Renaissance Harborplace Hotel, 202 East Pratt Street, Baltimore, MD 21202

DETAILS:

More than 140 leaders from the Baltimore region's bioscience industry and research community will attend a breakfast reception at the Greater Baltimore Committee to honor winners of the 2008 Greater Baltimore Region Bioscience Awards.

This is the third annual awards event presented by the Greater Baltimore Committee, the region's most prominent organization of business and civic leaders, to recognize outstanding achievements in the region's bioscience industry. The Greater Baltimore Committee has made support for the emerging bioscience industry in the region one of its top long-term priorities.

Award winners, to be announced, were selected from among 22 nominations submitted by businesses, bioscience advocates, higher education institutions and government officials.

Awards will be presented in the following categories: Best New Product or Progress Award, Entrepreneurship Award, Leadership in Bioscience Award, and President's Award.

Nominees for this year's awards are:

Best New Product or Progress Award

-- Kris Appel, President & CEO, Encore Path, Inc.

-- Timothy E. Askew, President & CEO, CSA Medical, Inc.

-- James Campbell, M.D., CEO, Arcion Therapeutics

-- William G. Hearl, Ph.D., Founder & President, Immunomic Therapeutics, Inc.

-- Ryan Sysko, Founder & CEO, WellDoc Communications, Inc.

Entrepreneurship Award

-- Mohamed S. Al-Ibrahim, MB ChB, FACP, COO & President, SNBL Clinical Pharmacology Center, Inc.

-- Scott Allocco, President, BioMarker Strategies, LLC

-- Atul Bedi, M.D., Founder, President & Chief Executive Officer, IATRICa Inc.

-- David S. Block, Founder & CEO, Gliknik, Inc.

-- Julie D. Suman, R.Ph., Ph.D., Co-founder & President, Next Breath, LLC

-- Reza Mazhari, Ph.D., VP, Research & Pharmacology and Peter Suzdak, Ph.D.,President/CEO & Co-founder, Cardioxyl Pharmaceuticals, Inc.

-- Jian Wang, Ph.D., President & CEO, BioFortis

Leadership in Bioscience Award

-- Drew M. Pardoll, M.D., Ph.D., Amplimmune

-- Blake M. Paterson, M.D., CEO and Co-founder, Alba Therapeutics Corporation

President's Award

-- Stephen P. Auvil, Co-PI, Director, Office of Technology Development, UMBC and the ACTiVATE Program

-- Delegate Dan K. Morhaim, M.D., The Maryland House of Delegates, 11th District, Baltimore County

-- David J. Ramsay, DM, DPhil, President, University of Maryland, Baltimore

-- John T. (Jack) Shannon, Jr., President and CEO, East Baltimore Development Inc. and Scott Levitan, Senior Vice President, Development Director, Forest City Science + Technology Group, Forest City - New East Baltimore Partnership

-- Paul Silber, Former President/CEO & Founder, InVitro Technologies, Inc.

-- Kathleen O'Donnell Weiss, Executive Director, The BioTechnical Institute of Maryland, Inc.

Program sponsor for the event is KAWG&F. Media sponsor is The Daily Record.

To attend and cover this event, contact: Diane Hughes, 410-727-2820, x32


'/>"/>
SOURCE Greater Baltimore Committee
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
2. University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
3. New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
4. GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral)
5. Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair
6. California Stem Cell Board Member Violates Conflict Rules; Should Resign From Committee, Consumer Group Says
7. Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings
8. California IVF Experts Tap Ethics Committee for Guidance
9. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
10. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
11. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... Non-profit Consortium Aims to Generate Genomic ... Research and Discovery --> --> ... plan to sequence 100,000 individuals. It is intended to initially ... 7 of North and East Asian countries. ... project will focus on creating phased reference genomes for all ...
(Date:2/11/2016)... Texas , Feb. 11, 2016  Vermillion, Inc. ... on gynecologic disease, today announced the formation of the ... --> --> Pelvic masses ... both diagnosis and management. Once pregnancy is ruled out, ... tubes and ovaries, advanced endometriosis, benign ovarian tumors and ...
(Date:2/11/2016)... NEW YORK , Feb. 11, 2016  Bioethics International, ... how medicines are researched, developed, marketed and made accessible to ... BMJ Open had named the publication of the ... for 2015. The publication is also featured as one of ... published in the last year that are most frequently read. ...
Breaking Biology Technology:
(Date:2/9/2016)... 9, 2016 Vigilant Solutions announces today that an ... to develop a lead in a difficult homicide case. The ... to locate the suspect vehicle. Due to the ongoing investigation, ... been omitted at the agency,s request. --> ... "Our victim was found deceased at an intersection here in ...
(Date:2/3/2016)... 2016 --> ... "Automated Fingerprint Identification System Market by Component (Hardware and ... & Finance, Government, Healthcare, and Transportation) and Geography - ... is expected to be worth USD 8.49 Billion by ... and 2020. The transformation and technology evolution from the ...
(Date:2/2/2016)... Checkpoint Inhibitors for Cancer – Explore ... you interested in the future of cancer drugs? ... Visiongain,s report gives those predictions to 2026 at ... Avoid falling behind in data or losing ... those emerging cancer therapies can achieve. There you ...
Breaking Biology News(10 mins):